EventsThe 1st International Electronic Conference on Pharmaceutics
Published
This submission belongs to the session B. Cyclodextrins in Pharmaceutics of the event The 1st International Electronic Conference on Pharmaceutics
Published date
01 Dec, 2020
Citation
Jéssica S. Barbosa, Karyna Lysenko, Susana Santos Braga, Filipe A. Almeida Paz, Inclusion of Montelukast in y-Cyclodextrin: Presenting a Mechanochemical Route to Improve Drug Stability and Solubility †, in Proceedings of The 1st International Electronic Conference on Pharmaceutics, 1 December–15 December 2020, MDPI: Basel, Switzerland, doi: 10.3390/IECP2020-08717
Share
Email
Facebook
Twitter
LinkedIn

Inclusion of Montelukast in y-Cyclodextrin: Presenting a Mechanochemical Route to Improve Drug Stability and Solubility

image
image
1. Department of Chemistry, LAQV-REQUIMTE, University of Aveiro, 3810-193 Aveiro, Portugal, Portugal
2. Department of Chemistry, CICECO – Aveiro Institute of Materials, University of Aveiro, 3810-193 Aveiro, Portugal
3. Department of Chemistry, LAQV-REQUIMTE, University of Aveiro, 3810-193 Aveiro, Portugal
Abstract

Montelukast sodium (MLK) is a worldwide anti asthmatic drug. Commercial formulations still have some issues with solubility and instability to light and humidity. To overcome them, the present work reports inclusion compounds of MLK and g-cyclodextrin (g-CD). As a molecular capsule, CDs have the ability to protect the inclusion guest from degradation, enhance its solubility and alter the pharmacokinetic parameters. MLK×g-CD inclusion compounds were prepared by mechanochemistry. Without using any solvent, g-CD was pre-milled and then co-milled with an equimolar quantity of MLK, in a ball mill at 600 cycles.min-1. After 120 min of milling, the formation of MLK·g-CD inclusion compounds was confirmed by powder X Ray diffraction and scanning electron microscopy. Additional studies, performed under Pharmacopeia guidelines, showed that the prepared MLK×g-CD inclusion compounds can indeed increase the dissolution of MLK drug when in ultra-pure water or simulated intestinal fluid (without pancreatin). This way, the MLK×g-CD inclusion compounds that are presented in this work are a promising solution for improving the therapeutic effectiveness of MLK drug.

Keywords
Montelukast
Cyclodextrins
Mechanochemistry
Inclusion Compounds
Drug Solubility
Manuscript
Oxyresveratrol Supplementation In Hyper-Branched Cyclodextrin Based Nanosponges As Antiaging Enhancer in Caenorhabditis Elegans
Lipid-based nanocarriers for Rose Bengal dermal delivery: a promising approach in melanoma treatment